Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma.

about

4-1BB agonism: adding the accelerator to cancer immunotherapy The application of CAR-T cell therapy in hematological malignancies: advantages and challenges

P2860

Q28079622-ABCA1499-BAF9-4DE3-82DA-D14E2673098C Q57177485-25C1E0C2-3482-443E-96DF-34F47AA41777

P2860

Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma.

Item

http://www.wikidata.org/entity/Q42533033

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@en

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@nl

type

Item

label

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@en

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@nl

prefLabel

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@en

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@nl

P1476

Construction of Anti-CD20 Sing ...... ent Effect on B Cell Lymphoma.

@en

P2093

Baoli He

http://www.w3.org/2001/XMLSchema#string

Chuming Fan

http://www.w3.org/2001/XMLSchema#string

Fei Chen

http://www.w3.org/2001/XMLSchema#string

Haixi Zhang

http://www.w3.org/2001/XMLSchema#string

Jie Lu

http://www.w3.org/2001/XMLSchema#string

Qian Liu

http://www.w3.org/2001/XMLSchema#string

Xiaoli Gao

http://www.w3.org/2001/XMLSchema#string

Xuezhong Gu

http://www.w3.org/2001/XMLSchema#string

Xun Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical application of adoptive T cell therapy in solid tumors

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.

The inside out of lentiviral vectors

Targeting tumours with genetically enhanced T lymphocytes.

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

Active and passive immunotherapy for lymphoma: proving principles and improving results.

Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.

Targeting CD28 to prevent transplant rejection.

P304

2110-2115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.893791

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26195067

http://www.w3.org/2001/XMLSchema#string

P932

4537073

http://www.w3.org/2001/XMLSchema#string

Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma.

about

P2860

P2860

Construction of Anti-CD20 Single-Chain Antibody-CD28-CD137-TCRζ Recombinant Genetic Modified T Cells and its Treatment Effect on B Cell Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932